Search 237 product updates by drug, renal measure or dialysis term. Each result identifies the formulation, the label used and the limits of its renal guidance.
Choose the starting dose from the Cockcroft-Gault CrCl table for the exact indication. Separate columns cover combination therapy, post-transplant maintenance or MDS, and follicular or marginal-zone lymphoma.
Limits and monitoring
Dialysis has a separate row with dosing after the session on dialysis days. Verify cycle days and blood counts before applying a schedule.
Adult immediate-release oral dosing uses CrCl adjusted to 1.73 m2. The dialysis row gives 500-1,000 mg every 24 hours and an additional 250-500 mg after dialysis.
Limits and monitoring
Use the labeled table for the other clearance bands. The XR and injection products have separate source records.
This summary uses the identified dated label. Verify the current label for this presentation before applying the regimen.
Renal measure
Creatinine clearance (CrCl), mL/min
Renal action or finding
The label lists silodosin 4 mg once daily with a meal for moderate impairment (CrCl 30-50 mL/min) and contraindicates use below 30.
Limits and monitoring
The cited mild (50-80) and moderate (30-50) ranges both print 50. At exactly 50 verify the current product label and clinical interpretation before choosing a dose.
In renal impairment select the interval by CrCl, monitor heart rate and QTc, and allow at least five doses at the appropriate interval before increasing the dose.
Limits and monitoring
Use the full initiation or reinitiation protocol. Hemodialysis removes some drug but the label supplies no dialysis regimen.
Renal impairment categories as defined by the cited product label
Renal action or finding
In recipients of a liver, heart or lung transplant with pre-existing renal impairment, consider the low end of the tacrolimus therapeutic dose range because of nephrotoxicity.
Limits and monitoring
Check trough concentrations, kidney function, route and transplant indication.
